Raphael Pharmaceutical Inc. (RAPH)
OTCMKTS · Delayed Price · Currency is USD
1.510
+0.110 (7.86%)
At close: Oct 16, 2026
Raphael Pharmaceutical Market Cap
Raphael Pharmaceutical has a market cap or net worth of $30.47 million as of October 30, 2026. It is the 33,724th most valuable company in the world and the 4,941st biggest in the United States. Its market cap has increased by 288.08% in one year.
Market Cap
30.47M
Enterprise Value
30.51M
Revenue
n/a
Global Rank
Country Rank
#4,941 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 5, 2023, Raphael Pharmaceutical's market cap has decreased from 34.37M to 30.47M, a decrease of -11.37%. That is a compound annual growth rate of -3.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 30.47M | 10.88% |
| Dec 24, 2025 | 27.48M | -20.06% |
| Jan 5, 2023 | 34.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sofgen Pharma | 59.82M |
| Cyphaira | 46.55M |
| Earth Science Tech | 29.91M |
| High Sierra Technologies | 28.98M |
| Bio Essence | 25.29M |
| Radnostix | 24.48M |
| MariMed | 20.72M |
| Healthy Extracts | 19.02M |